Project Grant H62PS003187

This federal Project Grant award of $819,603 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to implement novel strategies for long-acting antiretroviral therapy (ART) among people with criminal legal involvement (CLI) living with HIV. The project, titled "INSIDE START: Implementation of Novel Strategies for Long-Acting ART - People with Criminal Legal Involvement (CLI)," will be...

This $286,660 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to finalize intervention materials, clinical protocols, and an implementation plan for a nurse-led, same-day HIV pre-exposure prophylaxis (PrEP) initiation intervention with continuation of care services after incarceration. The grant recipient, Rhode Island Hospital, a division of Lifespan Corporation, will test this intervention through a preliminary...

This Project Grant award of $186,728 from the U.S. Department of Health and Human Services' National Research Service Awards Health Services Research Training program (CFDA 93.225) aims to design, implement, and evaluate an intervention to improve linkage to care for people experiencing homelessness after discharge from the emergency department. The key objectives are to (1) understand the facilitators and barriers to linkage-to-care for this population after emergency department discharge,...

This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...

This $576,900 project grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will implement and evaluate a peer recovery coach (PRC) program at three high-throughput jails in the Atlanta, Georgia area. The program aims to improve access to substance use disorder (SUD) treatment and medications for opioid use disorder (MOUD) for individuals in these jails, particularly Black individuals and those experiencing homelessness who face...

The Travis County Proposes to Implement a Continuity of Care Service Model Project is a $1,600,000 Project Grant award from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The project aims to connect services within the jail with ongoing community-based services immediately upon release from incarceration, with a focus on addressing opioid overdoses and deaths in the region. Key services to...

This Project Grant award of $769,471 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports the "HIV Enhanced Access Testing in Emergency Department Program Using a Systems Analysis and Improvement Approach (HEATED-SAIA) Cluster Randomized Trial". The program aims to enhance delivery of HIV testing services (HTS) in emergency departments (EDs) in Kenya, targeting hard-to-reach populations like men, adolescents,...

This Project Grant award of $3,210,845.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to develop methods for the real-time detection of Staphylococcus aureus transmission in hospital settings. The key products and services to be delivered under this award include: Integrating weekly patient colonization sampling with hospital-wide genomic surveillance to analyze phylogenetic relationships among S. aureus strains, in...

The U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) awarded a $150,000 Project Grant under the HIV-Related Training and Technical Assistance program (CFDA 93.145) to Prism Health North Texas, a non-profit organization based in Dallas, Texas. The grant will be used to establish sustainable collaborations with non-traditional partners serving justice-involved individuals living with HIV in Dallas County. The initiative aims to develop a...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $444,826, is focused on adapting and testing an innovative, trauma-informed intervention to reduce overdose risk among women re-entering the community from prison. The key activities include: 1) Adapting the Trust-Based Relational Intervention (TBRI) approach by engaging stakeholders to align it with the unique needs of justice-involved women,...